PATENT CLAIM ANALYSIS

Application Number: 15915637
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["424", "093710"]

Abstract:
Provided are methods for improving cell-based therapies by co-administration with an agent that increases the production and or levels of epoxygenated fatty acids, as well as kits, stents and patches for co-administering stem cells with an agent that increases the production and/or levels of epoxygenated fatty acids.

Claim (Index 32):
The method of  claim 31 , wherein the stem cells are selected from the group consisting of cardiomyocytes or cardiac progenitor cells derived from multipotent stem cells, cardiomyocytes or cardiac progenitor cells derived from pluripotent stem cells, cardiomyocytes or cardiac progenitor cells derived from induced pluripotent stem cells, adult cardiac progenitor cells and cardiac stem cells.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 90.0
- Lexical Diversity: 1.47059
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['11921676', '14384910', '11256685', '11685674', '11330033']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7668326056305313
- 35 USC 102 Novelty (BERT): 0.5474023173502087
- Combined Prediction Score: 0.7448895768024991
- Mean Citation Score: 322.81307400000014
- Max Citation Score: 416.39224
- Similarity Product: 246.652750442462

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test